chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Visual impairment
Clinical narrative: shingles; my eye sight is affected; This is a spontaneous report from a non-contactable consumer (patient herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported) via an unspecified route of administration on 29Mar2021 as the first dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced shingles. The patient's eye sight was also affected just when she was finishing up with her shingles on an unspecified date (it was reported that the patient needs to see her doctor because of this event). The outcome of shingles was recovering; and the outcome of the event eye sight was also affected was unknown. It was reported that the  patient have a second dose appointment (reported to be on Monday) and was inquiring how long does she have to postpone to get the second.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is needed.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Insomnia, Pain in extremity, Rash
Clinical narrative: rash on her arm./2 spots/it went down to her arm and elbow; Experiencing pain down her shoulder to her hand/excruciating pain/pain in her arm; shingles on her arm; hardly sleep at night; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on 29Mar2021 (at the age of 81 years old) as 2nd dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first vaccination of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on Mar2021 for COVID-19 immunization and had no reaction. It was reported that on 29Mar2021, she received the second dose and 10 days later (08Apr2021), she started experiencing pain down her shoulder to her hand. She described it as "excruciating pain". It lasted for almost 7 days and is still ongoing. She could hardly sleep at night due to the pain in her arm. It looks like she may have shingles on her arm, as per her doctor. She added that she now has a rash on her arm. Yesterday, she had 2 spots and today it went down to her arm and elbow. Her doctor prescribed her antivirals. The outcome of the events shingles on her arm, hardly sleep at night and rash on her arm./2 spots/it went down to her arm and elbow was unknown; outcome of Experiencing pain down her shoulder to her hand/excruciating pain/pain in her arm was not recovered. She also added that her daughter received the  vaccine and also has pain in her arm now.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: rash on her arm./2 spots/it went down to her arm and elbow; Experiencing pain down her shoulder to her hand/excruciating pain/pain in her arm; shingles on her arm; hardly sleep at night; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on 29Mar2021 (at the age of 81 years old) as 2nd dose, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first vaccination of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on Mar2021 for COVID-19 immunization and had no reaction. It was reported that on 29Mar2021, she received the second dose and 10 days later (08Apr2021), she started experiencing pain down her shoulder to her hand. She described it as "excruciating pain". It lasted for almost 7 days and is still ongoing. She could hardly sleep at night due to the pain in her arm. It looks like she may have shingles on her arm, as per her doctor. She added that she now has a rash on her arm. Yesterday, she had 2 spots and today it went down to her arm and elbow. Her doctor prescribed her antivirals. The outcome of the events shingles on her arm, hardly sleep at night and rash on her arm./2 spots/it went down to her arm and elbow was unknown; outcome of Experiencing pain down her shoulder to her hand/excruciating pain/pain in her arm was not recovered. She also added that her daughter received the  vaccine and also has pain in her arm now.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: rash; had developed shingles after the first dose; This is a spontaneous report from a contactable Health care Professional (Nurse). A 59-year-old female patient received first dose of BNT162B2 (BNT162B2) via an unspecified route of administration on 25Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced rash and had developed shingles after the first dose on 07Apr2021. It was reported that patient was given Antiviral medication, asked if safe to receive second CoVax. Last dose of antiviral medication will be given 4 days before second COVAX appointment. Therapeutic measures were taken as a result of had developed shingles after the first dose. Outcome of the events was unknown.   Information related to batch/Lot no. was requested.
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: Shortly after the shot she felt her throat was feeling swollen; This is a spontaneous report from a contactable consumer (patient). An adult female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number: unknown), via an unspecified route of administration in Mar2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were unknown. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. In Mar2021, shortly after the shot the patient felt her throat was feeling swollen. The patient said she went back to the site where administered and spoke with medical staff and was okay. The outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: L3802, expiration date not reported), via an unspecified route of administration, administered on the right arm on 29Jan2021 (at the age of 66-years-old), as second dose, single for COVID-19 immunisation. Medical history included ongoing multiple sclerosis from 1995 and immunodeficiency (reported as compromised immune system). The patient's concomitant medications were not reported. Patient was not receiving any drugs or injection for multiple sclerosis at this time. Patient reported that she did not receive additional vaccines on the same date of the second dose administration. Patient was not pregnant at time of vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4176, expiration date not reported), via an unspecified route of administration, administered on the right arm on 08Jan2021 (at the age of 66-years-old), as first dose, single for COVID-19 immunisation. It was also reported that the patient did not receive any vaccines within 4 weeks prior to the first COVID-19 vaccine. The patient experienced shingles on an unspecified date in 2021 (reported as 1 week after the second vaccine but patient cannot remember specific date). Patient reported that the marks were still there, but she is no longer contagious. There were no dripping of any kind and it had dried up. The event did not result to physician office visit nor emergency room visit. The outcome of the event was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 04Feb2021 11:15 (Lot Number: EN6202) (at the age of 84-years-old) as 1st dose, single, and dose 2 via an unspecified route of administration, administered in Arm Right on 25Feb2021 11:15 (Lot Number: EN5318) (at the age of 84-years-old) as 2nd dose, single for COVID-19 immunisation. Medical history included ongoing high blood pressure from 2011 (diagnosed around 10 years ago), and also had flu-like symptoms from an unknown date that occurred years ago, at least 20 years. Patient previously took flu shot on an unknown date at unspecified age (unknown manufacturer, NDC number, lot number, or expiry date) for immunization. Concomitant medication included lisinopril taken for high blood pressure from an unspecified date in 2011 (for probably 10 years) and ongoing. Patient reported that a couple of days (about 3-4 days) after receiving the first dose of the Covid-19 vaccine, she got shingles. Patient reported that by the time she went for the second vaccine, date later provided as 25Feb2021, the shingles were pretty well cleared up. Patient reported that she went to see her physician before getting the second dose of the Covid-19 vaccine. Patient reported that her physician stated that the shingles looked good, that they were almost cleared up, and the patient was ok to have the second dose of the Covid-19 vaccine. Patient reported that following the second dose of the Covid-19 vaccine on 25Feb2021, she had another reaction from the Covid-19 vaccine and experienced a recurrence of the shingles. Patient reported that she saw a doctor at the vaccination facility and told the physician that she had the shingles. She called her physician and her physician called in a prescription for her. Patient reported that at time of call on 13Apr2021, she was still suffering with the shingles. Patient reported that the shingles have gotten a little better. Patient reported that she wanted to let Pfizer know about the shingles, stating that she didn't know if anyone else has gotten shingles from the Covid-19 vaccine. Event required visit to physician's office. Event did not require visit to emergency room. The outcome of event was recovering.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Disease recurrence, Herpes zoster, Pain
Clinical narrative: extreme pain exactly like shingles; extreme pain exactly like shingles; extreme pain exactly like shingles and in that location where five years ago I had shingles; This is a spontaneous report from a contactable consumer (patient). An 85-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 05Mar2021 (not pregnant) (Batch/Lot Number: eng199) as 2nd dose, single for covid-19 immunisation. Medical history included shingles, transient ischaemic attack, hashimoto's disease, tachycardia, Known allergies: Clams, crabs, Known allergies: all opiods, all from an unknown date.Patient had her first dose of bnt162b2 (Lot number: eng201) for Covid-19 Immunization on 12Feb2021 on left arm. Concomitant medications included levothyroxine sodium (SYNTHROID); metoprolol; colecalciferol (VIT.D3); cyanocobalamin (B12 1000 SR); rosuvastatin calcium (CRESTOR); acetylsalicylic acid (ASPIRIN (E.C.). On Midnight of second dose (05Mar2021), extreme pain exactly like shingles and in that location where five years ago I had shingles. Pain persists with no relief at number 7 most times. The treatment for the adverse events was extra strong tylenol, ultrasound, gabapentin. No covid prior vaccination.Not covid test post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Back pain, Chills, Headache, Pyrexia
Clinical narrative: This is a spontaneous report from a Pfizer-sponsored program reported from a contactable consumer (patient). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 15Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 25Mar2021 at single dose for COVID-19 immunization. The patient experienced high fever, headache, back ache, chills and hair fall on an unspecified date in Apr2021. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Headache
Clinical narrative: weird dizziness; headache; her bp spikes significantly; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer-sponsored program.   A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 16Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient mentioned that she is a healthy person but in the morning, on 20Apr2021, she experienced weird dizziness, headache and her blood pressure (BP) spikes significantly. She asked if these are normal side effects and if it is something that she needs to consult. Outcome of all the events was unknown. Second dose will be on 07May2021.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Insomnia, Nausea, Pyrexia, Rash
Clinical narrative: developed a severe rash after getting the second shot of the Pfizer COVID-19 vaccine. The rash was on my back. It goes away and comes back. From yesterday it spread to my entire body.; fever; nausea; couldn't sleep; shingles; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date (at an unspecified age) at 2nd dose, single for COVID-19 immunization. Medical history included shingles, breast cancer in 2009 followed by lumpectomy with radiation treatment (during radiation treatment, she developed shingles, was sent by doctor to dermatology for treatment). The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (dose: 1) for COVID-19 immunization. It was reported that after getting the second shot of Pfizer COVID-19 vaccine, the patient developed a severe rash. The rash was on the patient's back. It goes away and comes back. From yesterday (as reported), the rash spread to the patient's entire body. The patient also had fever with nausea and could not sleep. The patient asked if she could take diphenhydramine hydrochloride (BENADRYL). The patient noticed that after the second shot of Pfizer vaccine on the third (as reported), the patient's rash got worst, it looked like shingles. Outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Pyrexia, Rash
Clinical narrative: developed a severe rash after getting the second shot of the Pfizer COVID-19 vaccine. The rash was on my back. It goes away and comes back. From yesterday it spread to my entire body.; fever; nausea; couldn't sleep; shingles; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date (at an unspecified age) at 2nd dose, single for COVID-19 immunization. Medical history included shingles, breast cancer in 2009 followed by lumpectomy with radiation treatment (during radiation treatment, she developed shingles, was sent by doctor to dermatology for treatment). The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (dose: 1) for COVID-19 immunization. It was reported that after getting the second shot of Pfizer COVID-19 vaccine, the patient developed a severe rash. The rash was on the patient's back. It goes away and comes back. From yesterday (as reported), the rash spread to the patient's entire body. The patient also had fever with nausea and could not sleep. The patient asked if she could take diphenhydramine hydrochloride (BENADRYL). The patient noticed that after the second shot of Pfizer vaccine on the third (as reported), the patient's rash got worst, it looked like shingles. Outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report received from contactable other HCP (patient). A 35-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient received first dose of the vaccine and reported to have had "shingles" on unspecified date. Reporter asked if this is normal. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: a little sore arm; This is a spontaneous report from a Pfizer-Sponsored Program Pfizer reported from a contactable consumer (patient). A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 14Apr2021 at single dose for COVID-19 immunization. The patient had a dental appointment on 10Apr2021 and took premedication named Clindamycin. Concomitant medication included clindamycin hcl (CLINDAMYCIN HCL) taken for premedication on an unspecified date in Apr2021. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 24Mar2021 at single dose for COVID-19 immunization. The patient was  wondering if Clindamycin interfere with the vaccine. The patient experienced a little sore arm on an unspecified date in Apr2021. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: This is a spontaneous report from a contactable consumer (patient reporting for herself). A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, on 29Mar2021, as a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On unspecified date in 2021, it was reported that the patient was due for her second dose, she but developed shingles and her doctor put her on valaciclovir (VALTREX). It was also queried if the valaciclovir will interfere with receiving the vaccine and if it's contraindicated in people who are immunocompromised. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Drug ineffective for unapproved indication
Clinical narrative: Then I took my first pfizer shot 4 weeks ago and haven't used my nebulizer since/I took my 2nd shot last saturday and my wheezing stopped; This is a spontaneous report from a contactable consumer (patient) received from a Pfizer-sponsored program. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included I had chronic asthma, I had 3 attacks in past 6 months and I was suffocating from an unknown date and unknown if ongoing. The patient reported then i took my first pfizer shot 4 weeks ago and haven't used my nebulizer since/i took my 2nd shot last saturday and my wheezing stopped on an unspecified date. Patient had chronic asthma. had 3 attacks in past 6 months. During latest attack, nothing worked. Patient was suffocating, was already on medication for past 2 years, used my nebulizer every morning and night so can breath. The action taken in response to the event for bnt162b2 was not applicable. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Eye pruritus, Facial pain, Herpes zoster
Clinical narrative: Face got shingles on its left side by my mouth but it's not a cold sore; red, hurt, little blisters and itching on left side of my face; it's gotten bitter; side of my face by my mouth is red, it hurt, little blisters; side of my face by my mouth is red, it hurt, little blisters; they are itching this is on the left side of my face; side of my face by my mouth is red, it hurt, little blisters; Feels like my face is swelling; Left eye is itchy; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on 22Apr2021 (Batch/Lot Number: ER8732) as 1ST DOSE, SINGLE for covid-19 immunisation.  Medical history included: Allergy, double amputee. Concomitant medications included lamotrigine (LAMOTRIGINE); alprazolam (XANAX); venlafaxine (VENLAFAXINE); aripiprazole (ABILIFY); diclofenac diethylamine (DIFENAC [DICLOFENAC DIETHYLAMINE]); diphenhydramine hydrochloride (BENADRYL); ibuprofen (IBUPROFEN); eszopiclone (LUNESTA); budesonide, formoterol fumarate (SYMBICORT);  (ALBUTEROL); all taken for unspecified indications, start and stop dates were not reported. The patient had her (first) Covid shot yesterday and her face got shingles on it now and it's on the left side by her mouth but it's not a cold sore. Reported as "shingles, on the side of my face by my mouth is red, it hurt, little blisters and they are itching this is on the left side of my face/ Face got shingles on its left side by my mouth but it's not a cold sore; red, hurt, little blisters and itching on left side of my face; it's gotten bitter. My left eye is itchy and it feels like my face is swelling." The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face
Clinical narrative: Face got shingles on its left side by my mouth but it's not a cold sore; red, hurt, little blisters and itching on left side of my face; it's gotten bitter; side of my face by my mouth is red, it hurt, little blisters; side of my face by my mouth is red, it hurt, little blisters; they are itching this is on the left side of my face; side of my face by my mouth is red, it hurt, little blisters; Feels like my face is swelling; Left eye is itchy; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on 22Apr2021 (Batch/Lot Number: ER8732) as 1ST DOSE, SINGLE for covid-19 immunisation.  Medical history included: Allergy, double amputee. Concomitant medications included lamotrigine (LAMOTRIGINE); alprazolam (XANAX); venlafaxine (VENLAFAXINE); aripiprazole (ABILIFY); diclofenac diethylamine (DIFENAC [DICLOFENAC DIETHYLAMINE]); diphenhydramine hydrochloride (BENADRYL); ibuprofen (IBUPROFEN); eszopiclone (LUNESTA); budesonide, formoterol fumarate (SYMBICORT);  (ALBUTEROL); all taken for unspecified indications, start and stop dates were not reported. The patient had her (first) Covid shot yesterday and her face got shingles on it now and it's on the left side by her mouth but it's not a cold sore. Reported as "shingles, on the side of my face by my mouth is red, it hurt, little blisters and they are itching this is on the left side of my face/ Face got shingles on its left side by my mouth but it's not a cold sore; red, hurt, little blisters and itching on left side of my face; it's gotten bitter. My left eye is itchy and it feels like my face is swelling." The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported that a female patient of an unspecified age received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date not reported), via an unspecified route of administration on 01Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient developed shingles on an unspecified date in Apr2021, within 48 hours after the COVID-19 vaccine. The patient wanted to know if should get her second dose on Monday. It was also reported that the patient is in severe agony and pain on an unspecified date in Apr2021. The outcome of the events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lymphadenopathy, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: High fever started about 10-12 hours after vaccine; ringing in ears; aches; left armpit lymph node is huge, looks like a ping pong ball; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in the left arm on 02Apr2021 at 15:00 (Batch/Lot Number: ER8734) as a single dose (at the age of 45-years-old) for COVID-19 immunization.  The patient medical history was not reported. The patient was not pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19.   Concomitant medications included levothyroxine sodium (SYNTHROID); nebivolol hydrochloride (MAXINEB); and vitamin d5 (VITAMIN D5); all from unknown dates taken for an unspecified indications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 03Apr2021 at 02:30 the patient experienced high fever, ringing in ears, aches and left armpit lymph node is huge. The patient stated high fever started about 10-12 hours after vaccine, ringing in ears (continued into day 3), aches and left armpit lymph node is huge, looks like a ping pong ball (very painful).  The events were reported as non-serious and did not require hospitalization or prolongation of hospitalization. The patient did not receive any therapeutic intervention for events high fever, ringing in ears, aches and left armpit lymph node is huge. The patient underwent lab tests and procedures which Covid test (nasal swab) on 03Jan2021 with result: negative.  It was also reported that since the vaccination, has the patient been tested for COVID-19 on an unknown date with unknown results. The clinical outcome of the events high fever, ringing in ears, aches and left armpit lymph node is huge was recovered with sequelae (reported as lasting effects) on unknown dates in 2021. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in the left arm on 23Apr2021 at 14:15 (Batch/Lot Number: EE0152) as a single dose for COVID-19 immunization.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: High fever started about 10-12 hours after vaccine; ringing in ears; aches; left armpit lymph node is huge, looks like a ping pong ball; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in the left arm on 02Apr2021 at 15:00 (Batch/Lot Number: ER8734) as a single dose (at the age of 45-years-old) for COVID-19 immunization.  The patient medical history was not reported. The patient was not pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19.   Concomitant medications included levothyroxine sodium (SYNTHROID); nebivolol hydrochloride (MAXINEB); and vitamin d5 (VITAMIN D5); all from unknown dates taken for an unspecified indications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 03Apr2021 at 02:30 the patient experienced high fever, ringing in ears, aches and left armpit lymph node is huge. The patient stated high fever started about 10-12 hours after vaccine, ringing in ears (continued into day 3), aches and left armpit lymph node is huge, looks like a ping pong ball (very painful).  The events were reported as non-serious and did not require hospitalization or prolongation of hospitalization. The patient did not receive any therapeutic intervention for events high fever, ringing in ears, aches and left armpit lymph node is huge. The patient underwent lab tests and procedures which Covid test (nasal swab) on 03Jan2021 with result: negative.  It was also reported that since the vaccination, has the patient been tested for COVID-19 on an unknown date with unknown results. The clinical outcome of the events high fever, ringing in ears, aches and left armpit lymph node is huge was recovered with sequelae (reported as lasting effects) on unknown dates in 2021. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in the left arm on 23Apr2021 at 14:15 (Batch/Lot Number: EE0152) as a single dose for COVID-19 immunization.  Information on Lot/Batch number was available. Additional information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: feeling tired for about 1 day after; This is a spontaneous report from a non-contactable consumer (Patient). An adult female patient received bnt162b2 (PFIZER BIONTECH COVID 19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling tired for about 1 day after with outcome of unknown. Unsure if it was first or second dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Sex: U
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: aches and pains; This is a spontaneous report from a contactable consumer (patient) received via a sales representative. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced aches and pains on an unspecified date after the second dose of vaccine. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: cold; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 07Apr2021 (Batch/Lot number: unknown) as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. In Apr2021, the patient experienced cold. She was scheduled to receive her second dose on 28Apr2021. She stated that she would not be able to make it to her scheduled appointment due to cold. She would like to know more information regarding what she should do about the second dose in regards to receiving it at a later date or if she has to start the vaccination series over again. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea
Clinical narrative: weakness; shortness of breath; dizziness; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient).  A male patient of an unspecified age received bnt162b2 (COVID 19 VACCINE), dose 1 via an unspecified route of administration on 03Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient experienced severe weakness, shortness of breath, and dizziness immediately after taking the shot on 03Apr2021 with outcome of unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Malaise, Nasal congestion, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: she has been having allergies; but has been having a stuffy nose, runny nose, sneezing,; but has been having a stuffy nose, runny nose, sneezing; but has been having a stuffy nose, runny nose, sneezing; a little bit of a sore throat; feeling ill; This is a spontaneous report received from a non contactable consumer(Patient). A female patient of an unknown age received first dose of BNT162B2( PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date not reported), via unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she has been having allergies and did a COVID rapid test today and was negative. She states she feels better, but has been having a stuffy nose, runny nose, sneezing, and a little bit of a sore throat. She is due for her second dose of Pfizer's COVID vaccine for Thursday, 29Apr2021. She asked if she should receive the second dose if she is feeling ill.  Response: Provided disclaimer that Pfizer is unable to make recommendations for individual patients and referred caller to HCP.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Sneezing
Clinical narrative: she has been having allergies; but has been having a stuffy nose, runny nose, sneezing,; but has been having a stuffy nose, runny nose, sneezing; but has been having a stuffy nose, runny nose, sneezing; a little bit of a sore throat; feeling ill; This is a spontaneous report received from a non contactable consumer(Patient). A female patient of an unknown age received first dose of BNT162B2( PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date not reported), via unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she has been having allergies and did a COVID rapid test today and was negative. She states she feels better, but has been having a stuffy nose, runny nose, sneezing, and a little bit of a sore throat. She is due for her second dose of Pfizer's COVID vaccine for Thursday, 29Apr2021. She asked if she should receive the second dose if she is feeling ill.  Response: Provided disclaimer that Pfizer is unable to make recommendations for individual patients and referred caller to HCP.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: She has had pain in that arm; It feels like something is crawling down her arm to her fingers that are numb and tingling; It feels like something is crawling down her arm to her fingers that are numb and tingling; This is a spontaneous report from a contactable consumer (reported on herself).  A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration in Arm Left on an unspecified date as 2nd dose, dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine includes BNT162B2 1st dose, single for COVID-19 immunization. Patient was a teacher, female and would like to know if numbness and tingling sensation are reported side effects of getting the BNT162B2. She experienced these side effects after getting the second dose of the vaccine. Patient states that she was calling to find out if something was a side effect of the COVID-19 Pfizer Shot. States that she had both doses of the shot in her left arm. For the past 2 and a half weeks she has had pain in that arm and it feels like something is crawling down her arm to her fingers that are numb and tingling. States she has discussed this with others who had the vaccine at the same time as her and a couple of them said they had it too. No further information or identifiers provided by patient. States she was about to go to the Emergency Room about this symptom. The outcome of the events was un-known.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Electric shock sensation, Heart rate increased
Clinical narrative: I felt like an electric shock in my body; something crawling inside her throat; Dizziness and lightheaded ness; Heart rate was up; I could not breathe properly; felt a sensation in her throat/t was like something was stuck in the upper part of her chest and throat; Panic attack; felt a sensation in her throat/t was like something was stuck in the upper part of her chest and throat; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), dose 1 via an unspecified route of administration on 21Apr2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that the day she got the vaccine she was ok but the next day around 10 am (22Apr2021) she had sudden dizziness and lightheadedness, her heart rate was up and felt she could not breathe properly. The patient opened the door to get oxygen, drank some water and ate, it took 1 hour and she felt better.  That same night she felt a sensation in her throat, she was able to breathe when she took deep breaths but it was like something was stuck in the upper part of her chest and throat, It lasted a few minutes. On Friday (23Apr2021) in the night she felt again something weird like something crawling inside her throat, she felt like an electric shock in her body and heart rate went up. She went out to take fresh air and felt better. The patient did go to the hospital on Friday night, they checked her oxygen and lungs it was ok, it was normal.  The patient was told at the hospital that she could take the 2nd dose, was told it could be a panic attack, not likely an allergic reaction. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Oxygen saturation, Panic attack, Sensation of foreign body
Clinical narrative: I felt like an electric shock in my body; something crawling inside her throat; Dizziness and lightheaded ness; Heart rate was up; I could not breathe properly; felt a sensation in her throat/t was like something was stuck in the upper part of her chest and throat; Panic attack; felt a sensation in her throat/t was like something was stuck in the upper part of her chest and throat; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), dose 1 via an unspecified route of administration on 21Apr2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that the day she got the vaccine she was ok but the next day around 10 am (22Apr2021) she had sudden dizziness and lightheadedness, her heart rate was up and felt she could not breathe properly. The patient opened the door to get oxygen, drank some water and ate, it took 1 hour and she felt better.  That same night she felt a sensation in her throat, she was able to breathe when she took deep breaths but it was like something was stuck in the upper part of her chest and throat, It lasted a few minutes. On Friday (23Apr2021) in the night she felt again something weird like something crawling inside her throat, she felt like an electric shock in her body and heart rate went up. She went out to take fresh air and felt better. The patient did go to the hospital on Friday night, they checked her oxygen and lungs it was ok, it was normal.  The patient was told at the hospital that she could take the 2nd dose, was told it could be a panic attack, not likely an allergic reaction. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood bilirubin, Blood bilirubin increased
Clinical narrative: Elevated (doubled) bilirubin; This is a spontaneous report received from a contactable pharmacist.   A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) dose 1 via an unspecified route of administration, on 18Mar2021 and dose 2 on 08Apr2021 as a single dose, for covid-19 immunisation. Medical history of the patient included metastatic breast cancer and Gilbert disease. Concomitant medications were not reported. On an unspecified date in 2021, the patient experienced elevated (doubled) bilirubin after her vaccine series. Outcome of event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021473014 same reporter/drug/AE, different patients(2nd of 3 patients);US-PFIZER INC-2021473015 same reporter/drug/AE, different patients (3rd of 3 patients);US-PFIZER INC-2021473013 same reporter/drug/AE, different patients (1st of 3 patients)
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: swelling upon administration; This is a spontaneous report from a contactable consumer (patient).   A 63-year-old adult male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration at the "top of the arm" on unknown date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and the patient's concomitant medications were not reported.  The patient experienced minimal to no pain (only some swelling upon administration) on an unspecified date with outcome of unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, SARS-CoV-2 antibody test, Tinnitus
Clinical narrative: partial hearing loss, 20%; tinnitus; This is a spontaenous report from a contactable consumer. A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 19Mar2021 (Lot Number: ER2613) as 1ST DOSE, SINGLE  for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced partial hearing loss, 20% and tinnitus on an unspecified date. The patient underwent lab tests and procedures which included Sars-Cov-2 antibody test: negative on 26Apr2021. Outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash in face and back; This is a spontaneous report from a contactable consumer (patient herself). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 07Jan2021 14:30 (Batch/Lot Number: Ej1686) as 1st dose, single for COVID-19 immunisation. Medical history included immunoglobulin g4 related disease (IGG4-RD) and rheumatoid arthritis. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported.  The patient previously took rituxan and experienced allergies. The patient experienced rash in face and back on an unspecified date in Jan2021. The outcome of event was recovering.    Information about bat/lot number has been obtained.